Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishment and Exploitation of a European-Latin American Research Consortium Towards Eradication of Preventable Gallbladder Cancer - EULAT Eradicate GBC

NCT06192719 is registered in ClinicalTrials.gov with Centre Paul Strauss as lead sponsor.

NCT NCT06192719
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06192719 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishment and Exploitation of a European-Latin American Research Consortium Towards Eradication of Preventable Gallbladder Cancer - EULAT Eradicate GBC
Lead sponsor
Centre Paul Strauss
Phase
Observational
Overall status
Recruiting
Start date
December 1, 2019
Completion date
December 31, 2028
Enrollment
15,000 (estimated)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

gallbladder cancer, gallstone disease